Last Action | 04/01/25: filed without Governor's signature with the Secretary of State |
---|---|
Title | AN ACT relating to pharmaceutical drugs. |
Bill Documents |
Current/Final
Introduced |
Bill Request Number | 1362 |
Sponsors | M. Whitaker, D. Lewis |
Summary of Original Version | Create a new section of KRS Chapter 315 to establish requirements for pharmacists when dispensing prescriptions in the event of a practitioner's death. |
Index Headings of Original Version |
Deaths - Prescription drug dispensing, deceased practitioners, requirements Drugs and Medicines - Prescription drug dispensing, pharmacists, requirements Health and Medical Services - Prescription drug dispensing, pharmacists, requirements Pharmacists - Prescription drug dispensing, practitioners, requirements Physicians and Practitioners - Prescription drug dispensing, pharmacists, requirements |
Jump to Proposed Amendments |
House Floor Amendment 1 Senate Floor Amendment 1 Senate Floor Amendment 2 |
Votes | Vote History |
02/13/25 |
|
---|---|
02/21/25 |
|
02/27/25 |
|
02/28/25 |
|
03/04/25 |
|
03/05/25 |
|
03/06/25 |
|
03/11/25 |
|
03/12/25 |
|
03/13/25 |
|
03/27/25 |
|
03/28/25 |
|
04/01/25 |
|
Amendment | House Floor Amendment 1 |
---|---|
Sponsor | M. Whitaker |
Summary | Establish requirements for pharmacists dispensing prescriptions in the event of a practitioner's death. |
Index Headings |
Deaths - Prescription drug dispensing, deceased practitioners, requirements Drugs and Medicines - Prescription drug dispensing, pharmacists, requirement Health and Medical Services - Prescription drug dispensing, pharmacists, requirement Pharmacists - Prescription drug dispensing, practitioners, requirement Physicians and Practitioners - Prescription drug dispensing, pharmacists, requirement |
Amendment | Senate Floor Amendment 1 |
---|---|
Sponsor | R. Mills |
Summary | Make title amendment. |
Index Headings | Title Amendments - HB 501/GA |
Amendment | Senate Floor Amendment 2 |
---|---|
Sponsor | R. Mills |
Summary | Amend RS 2025 HB 495/VO Section 1 to limit the prohibition on Medicaid expenditures for cross-sex hormones to instances of the cross-sex hormones being prescribed or administered primarily or solely for the treatment of gender dysphoria. |
Index Headings |
Drugs and Medicines - Medicaid, coverage, cross-sex hormones Public Assistance - Medicaid, coverage, cross-sex hormones Public Medical Assistance - Medicaid, coverage, cross-sex hormones Medicaid - Coverage, cross-sex hormones |
Last updated: 4/1/2025 2:25 PM (EDT)